Słowínska-Srzednicka J, Zgliczyński S, Ciświcka-Sznajderman M, Srzednicki M, Soszyński P, Biernacka M, Woroszyłska M, Ruzyłło W, Sadowski Z
Department of Endocrinology, Medical Center for Postgraduate Education, Warsaw, Poland.
Atherosclerosis. 1989 Oct;79(2-3):197-203. doi: 10.1016/0021-9150(89)90124-x.
Plasma levels of dehydroepiandrosterone sulfate (DHEA-S), testosterone, dihydrotestosterone (DHT) androstenedione, sex hormone-binding globulin (SHBG), lipoproteins, apolipoproteins and high density lipoprotein (HDL) subfraction were measured in 32 men aged 26-40 years after myocardial infarction (MI) suffered at least 3-4 months prior to the study, who were normocholesterolemic and had angiographically demonstrated coronary occlusion. The control group consisted of 76 healthy men aged 25-40 years. Blood samples were obtained in the morning from fasting subjects. A significant decrease in plasma DHEA-S and DHT levels were found in MI patients. Also, a significant decrease in HDL-cholesterol, HDL2-cholesterol (HDL2-C) and apolipoprotein A-I, an increase in apolipoprotein B and LDL-cholesterol (LDL-C) levels were observed in those patients as compared with healthy men. However, there were no differences in testosterone, androstenedione and SHBG concentrations between the groups. Significant correlations between testosterone and HDL2-C (r = 0.46, P less than 0.01), as well as between DHEA-S and HDL3-C (r = 0.39, P less than 0.05) levels in MI patients were observed. These results suggest that decreased levels of plasma DHEA-S and DHT may promote the development of coronary atherosclerosis in men.
对32名年龄在26至40岁之间、在研究前至少3至4个月发生心肌梗死(MI)、胆固醇正常且血管造影显示冠状动脉闭塞的男性,测定其血浆硫酸脱氢表雄酮(DHEA-S)、睾酮、双氢睾酮(DHT)、雄烯二酮、性激素结合球蛋白(SHBG)、脂蛋白、载脂蛋白和高密度脂蛋白(HDL)亚组分水平。对照组由76名年龄在25至40岁之间的健康男性组成。在早晨从空腹受试者采集血样。发现MI患者血浆DHEA-S和DHT水平显著降低。此外,与健康男性相比,这些患者的高密度脂蛋白胆固醇、高密度脂蛋白2胆固醇(HDL2-C)和载脂蛋白A-I水平显著降低,载脂蛋白B和低密度脂蛋白胆固醇(LDL-C)水平升高。然而,两组之间睾酮、雄烯二酮和SHBG浓度没有差异。观察到MI患者中睾酮与HDL2-C之间(r = 0.46,P < 0.01)以及DHEA-S与HDL3-C之间(r = 0.39,P < 0.05)存在显著相关性。这些结果表明,血浆DHEA-S和DHT水平降低可能促进男性冠状动脉粥样硬化的发展。